Advanced Filters
noise

Taipei County, Taiwan Clinical Trials

A listing of Taipei County, Taiwan clinical trials actively recruiting patients volunteers.

Found 981 clinical trials
Y Yen-Nung Lin, MD, MS

Effects of Home-based Surface Electrical Stimulation for Patients with Cervical Myofascial Pain Syndrome

The aim of this study is to compare the developed home-based surface electrical stimulation program to the controls in computer office workers with MPS.

20 - 60 years of age All Phase N/A
Y Yeu-Chin chen

A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)

Study Objectives\* Provide a systematic evaluation of the treatment outcomes in patients with hemophilia A Emphasize the importance and clinical benefits of rFVIII-Fc in joint and bone health. Compare the clinical outcomes from 1 year before and after switching to EHL. Exploratory: Identify biomarkers that could provide more useful and …

years of age Male Phase N/A
A Annette Opat

A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer

The goal of this clinical trial is To assess the safety and tolerability of PEP07 administered orally as a single dose and at escalating dose levels, and, to determine the dose-limiting toxicity (DLT) of study treatment in patients with Acute Myeloid Leukemia (AML) and Mantle Cell Lymphoma (MCL). To determine …

18 years of age All Phase 1
Y Yi Ling Chien, M.D., Ph.D.

Sensory Phenotypes of Autism Spectrum Disorder

This project plans to establish sensory phenotypes of a Taiwanese ASD cohort across lifespan, including variety of sensory modalities, sensory domains, and clinical correlates. Also, we will clarify the relationship between sensory phenotypes and social impairment by two specific sensory-social paradigms targeting eye gaze avoidance and social touch anxiety, as …

18 years of age All Phase N/A
Y Yen-Shen Lu, MD, PhD

Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC

This is an open-label randomized phase II study in estrogen receptor positive locally advanced or metastatic breast cancer patients. The main inclusion population are either luminal subtype B by PAM50 analysis or failed less than 2 lines of hormonal therapy for locally advanced or metastatic breast cancer. The subjects have …

20 years of age Female Phase 2
T Tien-Ni Wang, PhD

Geometric-Based Handwriting Intervention: Development, Feasibility and Randomized Clinical Trial

This study will focus on (1) developing the Chinese characteristic-based VMI-focused program, namely visual-perception motor-coordination integration program (CCVPMCI) involving the most Chinese-handwriting-related skills training and (2) investigating the effectiveness of the CCVPMCI program on handwriting performance in children with handwriting difficulties in Taiwan.

7 - 12 years of age All Phase N/A
L Li-Kai Tsai, MD, PhD

Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP

Patient with amyotrophic lateral sclerosis (ALS) having anti-NRIP autoantibody showed titer-dependent detrimental Effects. Plasmapheresis might benefit this subgroup of patients via removal of anti-NRIP autoantibody

20 years of age All Phase N/A

SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease

This study aims to conduct a randomized, double blind, randomised controlled multicentre trial of sirolimus drug coated balloon versus standard percutaneous transluminal angioplasty for the treatment of below the knee arterial disease.

21 years of age All Phase N/A
W Wei-Chen Lee, M.D.

Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma

This is an open-label, single arm, multicenter, Phase II clinical study to investigate the efficacy and safety profiles of autologous ATL administration in HCC patients after curative treatment. Among all the eligible patients, ratio of 7:2:1 for Stage I:II:IIIa of the HCC will be the enrolled strategy of the study …

20 years of age All Phase 2
I I-Rue Lai, MDPHD

Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis

Background: Approximately 15% of gastric adenocarcinoma patients presents with peritoneal carcinomatosis (PC) at the first encounter and is regarded as an unresectable and end-stage disease. The recommended treatment with palliative chemotherapy alone yields a poor clinical efficacy. Emerging evidences suggest the survival benefits of complete cytoreductive surgery (CRS) combined with …

20 - 75 years of age All Phase N/A

Simplify language using AI